You just read:

Caris Life Sciences Announces Published Results Showing that its ADAPT Biotargeting System Effectively Stratified Breast Cancer Patients Based on Their Benefit from Trastuzumab Treatment (Herceptin)

News provided by

Caris Life Sciences

Mar 23, 2018, 06:30 ET